Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:51 pm Purchase | 2025-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 5,700,000 6.500% | 1,050,000![]() (+22.58%) | Filing History |
| 2025-11-05 4:13 pm Sale | 2025-11-03 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 4,240,068 4.800% | -3,322,903![]() (-43.94%) | Filing History |
| 2025-10-31 11:31 am Purchase | 2025-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | The Vanguard Group | 4,559,917 5.210% | 4,559,917![]() (New Position) | Filing History |
| 2025-09-16 6:00 pm Purchase | 2025-09-09 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 4,650,000 5.300% | 4,650,000![]() (New Position) | Filing History |
| 2025-08-14 08:51 am Purchase | 2025-06-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 7,495,000 8.580% | 1,918,442![]() (+34.40%) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 4,305,204 4.930% | -929,304![]() (-17.75%) | Filing History |
| 2025-05-15 08:47 am Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 5,576,558 6.390% | -523,442![]() (-8.58%) | Filing History |
| 2025-05-07 11:29 am Purchase | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | MORGAN STANLEY MS | 7,099,954 8.100% | 7,099,954![]() (New Position) | Filing History |
| 2025-02-14 6:25 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Citadel Advisors LLC | 3,465,307 4.100% | 54,543![]() (+1.60%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 5,234,508 6.160% | 5,234,508![]() (New Position) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Soleus Capital Master Fund, L.P. | 8,142,500 9.600% | 1,918,956![]() (+30.83%) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 5,743,482 6.800% | 1,044,711![]() (+22.23%) | Filing History |
| 2024-11-15 10:35 am Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 2,894,093 3.500% | -1,027,133![]() (-26.19%) | Filing History |
| 2024-11-14 7:00 pm Purchase | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Capital Fund VIII L.P. | 4,597,243 5.400% | 4,597,243![]() (New Position) | Filing History |
| 2024-11-14 5:51 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 3,516,889 4.990% | -980,228![]() (-21.80%) | Filing History |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 0 0.000% | -6,632,015![]() (Position Closed) | Filing History |
| 2024-11-14 3:41 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -5,837,126![]() (Position Closed) | Filing History |
| 2024-11-14 3:30 pm Purchase | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Soleus Capital Master Fund, L.P. | 6,223,544 7.300% | 2,882,424![]() (+86.27%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 4,698,771 5.600% | 0 (Unchanged) | Filing History |
| 2024-11-05 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 1,628,534 1.900% | -1,851,096![]() (-53.20%) | Filing History |

